ALLR Allarity Therapeutics
- 1.0000
- -0.2300-18.70%
- 1.0400
- +0.0400+4.00%
Allarity Therapeutics News
AEON Biopharma, Allarity Therapeutics, ModivCare Among Healthcare Movers
Allarity Therapeutics' Stenoparib Shows Promise in Ovarian Cancer Trial
Why Is Nano-Cap Allarity Therapeutics Stock Trading Up On Thursday?
Allarity Therapeutics Inc (NASDAQ:ALLR) shares are trading higher on a strong session volume of 67 million, as per the data from Benzinga Pro.The company announced the early discontinuation of its Pha
Nasdaq Jumps Over 100 Points; Kellanova Posts Upbeat Results
U.S. stocks traded higher this morning, with the Nasdaq Composite surging over 100 points on Thursday.Following the market opening Thursday, the Dow traded up 0.48% to 38,085.28 while the NASDAQ rose
Wall Street Set to Open Higher Thursday After Fed Holds Rate Steady, Jobless Claims Lower Than Expected
US stocks look set to open higher in Thursday's trading session following the Federal Reserve's decision to leave rates unchanged Wednesday, and after jobless claims came in lower than expected earlie
Market-Moving News May 2nd
ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ov
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersAllarity Therapeutics (NASDAQ:ALLR) stock moved upwards by 106.6% to $2.83 during Thursday's pre-market session. The market value of their outstanding shares is at $5.5 million. Emergent BioSol
Allarity Therapeutics' Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone With Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
Boston (May 2, 2024)—Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the early
Allarity Therapeutics Maintains NASDAQ Compliance With Bid Price
Allarity Therapeutics Regains Compliance With NASDAQ Minimum Bid Price Requirement
Boston (April 29, 2024) — Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that on
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNuwellis (NASDAQ:NUWE) stock rose 46.8% to $0.48 during Monday's after-market session. The company's market cap stands at $3.2 million. Sensei Biotherapeutics (NASDAQ:SNSE) stock rose 7.42% to
Predictive Oncology, BIMI Holdings, IMAC Holdings Among Healthcare Movers
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 9.0% to $4.58 during Thursday's after-market session. The company's market cap stands at $3.4 million. Biora Therapeutics (NASDAQ:BIOR) share
Allarity Therapeutics Granted Extension for Nasdaq Compliance
Allarity Therapeutics Offering 5M Shrs at Assumed Public Offering Price of $2 Each
Allarity Therapeutics Offering 5M Shrs at Assumed Public Offering Price of $2 Each
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance With Nasdaq Listing Rule 5550(b)(1)
Boston (April 17, 2024)—Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that it had
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersSoligenix (NASDAQ:SNGX) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. Longeveron (NASDAQ:LGVN) shares increased by 51.47
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Shares of Medical Properties Trust, Inc. (NYSE:MPW) rose sharply in today's pre-market trading after the company announced that it sold its majority interest in Utah Hospitals. Medical Properties Tru
12 Health Care Stocks Moving In Friday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) stock moved upwards by 50.4% to $1.14 during Friday's after-market session. The company's market cap stands at $40.7 million. Allarity Therapeutics (NASDAQ:ALLR
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of JPMorgan Chase & Co. (NYSE:JPM) fell sharply during Friday's session following first-quarter earnings. Net revenue (managed) of $42.5 billion (+8% Y/Y), beating the consensus of $41.8 billi
Analysis
Price Target
No Data
